posteditor

posteditor

WhiteFiber, Inc. Reports First Quarter 2026 Results

B NEW YORK, May 14, 2026 /PRNewswire/ — WhiteFiber, Inc. (Nasdaq: WYFI) (“WhiteFiber” or the “Company”), a leading provider of AI infrastructure and high-performance computing… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

GEMMABio Unveils Duchenne Muscular Dystrophy (DMD) Program and Presents Preclinical Data for Next‑Generation Gene Therapies for DMD and Spinal Muscular Atrophy Type 1 (SMA1) at the ASGCT 2026 Annual Meeting

B -DMD preclinical data support candidate declaration for GB703, a potential DMD gene therapy designed to broaden mutation coverage and improve muscle delivery -SMA1 preclinical… Login to continue reading Login Sign up for complimentary access Sign Up Now Close